Aldo-keto reductases AKR1C1, AKR1C2 and AKR1C3 may enhance progesterone metabolism in ovarian endometriosis

article OA: closed CC0 ⤵ 16 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
AI-generated summary by claude@2026-06, 2026-06-07

This study investigated how aldo-keto reductases AKR1C1, AKR1C2, and AKR1C3 might influence progesterone metabolism within ovarian endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

mesh:D004715endometriosis

MeSH descriptors

Endometriosis Hydroxysteroid Dehydrogenases Hydroxysteroid Dehydrogenases Progesterone 20-Hydroxysteroid Dehydrogenases 20-Hydroxysteroid Dehydrogenases 20-Hydroxysteroid Dehydrogenases 3-alpha-Hydroxysteroid Dehydrogenase (B-Specific) 3-Hydroxysteroid Dehydrogenases 3-Hydroxysteroid Dehydrogenases 3-Hydroxysteroid Dehydrogenases 3-Oxo-5-alpha-Steroid 4-Dehydrogenase 3-Oxo-5-alpha-Steroid 4-Dehydrogenase Adult Aldo-Keto Reductase Family 1 Member C3 Down-Regulation Endometriosis Endometriosis Endometriosis Estradiol Dehydrogenases

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (61)

Cited by (16)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:16:54.825375+00:00
unpaywall
last seen: 2026-06-04T02:00:05.705006+00:00
License: CC0 · commercial use OK